Literature DB >> 921744

The combining site of the dinitrophenyl-binding immunoglobulin A myeloma protein MOPC 315.

S K Dower, S Wain-Hobson, P Gettins, D Givol, W R Jackson, S J Perkins, C A Sunderland, B J Sutton, C E Wright, R A Dwek.   

Abstract

Magnetic-resonance techniques are used to refine the model of the combining site of the Fv fragment of the dinitrophenyl-binding mouse myeloma protein MOPC 315 constructed by Padlan, Davies, Pecht, Givol & Wright (1976) (Cold Spring Harbor Symp. Quant. Biol.41, in the press). Light-absorption studies indicate a dinitrophenyl-tryptophan interaction in the Fv fragment of the type occurring in free solution. The Dnp-aspartate-tryptophan complex is therefore used as a starting point for the n.m.r. (nuclear-magnetic-resonance) analysis of the dinitrophenyl-Fv fragment interaction. Ring-current calculations are used to determine the geometry of the complex. The specificity of complex-formation between dinitrophenyl and tryptophan is confirmed by the lack of ring-current shifts of the dinitrophenyl resonances when tryptophan is replaced by any other aromatic amino acid. Proton n.m.r. difference spectra (at 270MHz), resulting from the addition of a variety of haptens to the Fv fragment, show that the combining site is highly aromatic in nature. Calculations on the basis of ring-current shifts define the geometry of the combining site, which involves a dinitrophenyl ring in van der Waals contact with four aromatic amino acid residues on the protein. The observation of a nuclear Overhauser effect on the H((3)) resonance of the dinitrophenyl ring provides additional constraints on the relative geometry of the H((3)) proton and an aromatic amino acid residue on the Fv fragment. The specificity of the Fv fragment for dinitrophenyl ligands arises from a stacking interaction of the dinitrophenyl ring with tryptophan-93(L), in an ;aromatic box' of essentially tryptophan-93(L), phenylalanine-34(H) and tyrosine-34(L); asparagine-36(L) and tyrosine-34(L) also contribute by forming hydrogen bonds with the nitro groups on the dinitrophenyl ring. The n.m.r. results also confirm that the antibody-hapten reaction may be visualized as a single encounter step. An Appendix shows the method of calculation of ring currents for the four aromatic amino acids and their use in calculating structures.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 921744      PMCID: PMC1164891          DOI: 10.1042/bj1650207

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Interactions of the lanthanide- and hapten-binding sites in the Fv fragment from the myeloma protein MOPC 315.

Authors:  R A Dwek; D Givol; R Jones; A C McLaughlin; S Wain-Hobson; A I White; C Wright
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

2.  Antibody--hapten interactions in solution.

Authors:  R A Dwek; R Jones; D Marsh; A C McLaughlin; E M Press; N C Price; A I White
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1975-11-06       Impact factor: 6.237

3.  An active antibody fragment (Fv) composed of the variable portions of heavy and light chains.

Authors:  J Hochman; D Inbar; D Givol
Journal:  Biochemistry       Date:  1973-03-13       Impact factor: 3.162

4.  Electron microscopy of an antibody-hapten complex.

Authors:  R C Valentine; N M Green
Journal:  J Mol Biol       Date:  1967-08-14       Impact factor: 5.469

5.  Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315.

Authors:  H N Eisen; E S Simms; M Potter
Journal:  Biochemistry       Date:  1968-11       Impact factor: 3.162

6.  Kinetic mapping of the antibody combining site by chemical relaxation spectrometry.

Authors:  D Haselkorn; S Friedman; D Givol; I Pecht
Journal:  Biochemistry       Date:  1974-05-07       Impact factor: 3.162

7.  Circular dichroism studies on the interactions of haptens with MOPC-315 and MOPC-460 mouse myeloma proteins and specific antibodies.

Authors:  J H Rockey; P C Montgomery; B J Underdown; K J Dorrington
Journal:  Biochemistry       Date:  1972-08-15       Impact factor: 3.162

Review 8.  Affinity labeling and topology of the antibody combining site.

Authors:  D Givol
Journal:  Essays Biochem       Date:  1974       Impact factor: 8.000

9.  Specificity of interactions of hapten side chains with the combining site of the myeloma protein MOPC 315.

Authors:  S Wain-Hobson; S K Dower; P Gettins; D Givol; A C McLaughlin; I Pecht; C A Sunderland; R A Dwek
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

10.  The three-dimensional structure of the fab' fragment of a human myeloma immunoglobulin at 2.0-angstrom resolution.

Authors:  R J Poljak; L M Amzel; B L Chen; R P Phizackerley; F Saul
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

View more
  9 in total

1.  Modeling the antigen combining site of an anti-dinitrophenyl antibody, ANO2.

Authors:  D Bassolino-Klimas; R E Bruccoleri; S Subramaniam
Journal:  Protein Sci       Date:  1992-11       Impact factor: 6.725

2.  The gross architecture of an antibody-combining site as determined by spin-label mapping.

Authors:  B J Sutton; P Gettins; D Givol; D Marsh; S Wain-Hobson; K J Willan; R A Dwek
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

3.  Comparison of the dimensions of the combining sites of the dinitrophenyl-binding immunoglobulin A myeloma proteins MOPC 315, MOPC 460 and XRPC 25 by spin-label mapping.

Authors:  K J Willan; D Marsh; C A Sunderland; B J Sutton; S Wain-Hobson; R A Dwek; D Givol
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

Review 4.  Structural correlates of immunoglobulin diversity.

Authors:  M Potter
Journal:  Surv Immunol Res       Date:  1983

5.  Specificity of interactions of hapten side chains with the combining site of the myeloma protein MOPC 315.

Authors:  S Wain-Hobson; S K Dower; P Gettins; D Givol; A C McLaughlin; I Pecht; C A Sunderland; R A Dwek
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

6.  The binding of 2,4,6-trinitrophenyl derivatives to the mouse myeloma immunoglobulin A protein MOPC 315.

Authors:  S K Dower; P Gettins; R Jackson; R A Dwek; D Givol
Journal:  Biochem J       Date:  1978-01-01       Impact factor: 3.857

7.  Resonance Raman-spectroscopic studies of the hapten features involved in the binding of 2,4-dinitrophenyl haptens by the mouse myeloma proteins MOPC 315 and MOPC 460.

Authors:  K Kumar; D J Phelps; P R Carey; N M Young
Journal:  Biochem J       Date:  1978-11-01       Impact factor: 3.857

8.  The variability of nitro group--protein interaction in the 2,4-dinitrophenyl-binding antibodies M315, M460 and X25 investigated by resonance Raman spectroscopy.

Authors:  P Gettins; R A Dwek; R N Perutz
Journal:  Biochem J       Date:  1981-07-01       Impact factor: 3.857

9.  The role of nitro groups in the binding of nitroaromatics to protein MOPC 315.

Authors:  P Gettins; D Givol; R A Dwek
Journal:  Biochem J       Date:  1978-09-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.